Robert Michael Savel II
Net Worth
Last updated:
What is Robert Michael Savel II net worth?
The estimated net worth of Mr. Robert Michael Savel II is at least $5,243,016 as of 28 Mar 2022. He owns shares worth $16,024 as insider, has earned $13,692 from insider trading and has received compensation worth at least $5,213,300 in Otonomy, Inc..
What is the salary of Robert Michael Savel II?
Mr. Robert Michael Savel II salary is $521,330 per year as Chief Technical Officer in Otonomy, Inc..
How old is Robert Michael Savel II?
Mr. Robert Michael Savel II is 57 years old, born in 1968.
What stocks does Robert Michael Savel II currently own?
As insider, Mr. Robert Michael Savel II owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Otonomy, Inc. (OTIC) | Chief Technical Officer | 145,735 | $0.11 | $16,024 |
What does Otonomy, Inc. do?
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Robert Michael Savel II insider trading
Otonomy, Inc.
Mr. Robert Michael Savel II has made 5 insider trades between 2015-2022, according to the Form 4 filled with the SEC. Most recently he sold 3,325 units of OTIC stock worth $8,023 on 28 Mar 2022.
The largest trade he's ever made was exercising 25,000 units of OTIC stock on 15 Jun 2015. As of 28 Mar 2022 he still owns at least 145,735 units of OTIC stock.
Otonomy key executives
Otonomy, Inc. executives and other stock owners filed with the SEC:
- Dr. David Allen Weber (65) Pres, Chief Executive Officer & Director
- Dr. Jay B. Lichter Ph.D. (63) Co-Founder & Independent Chairman
- Mr. Paul E. Cayer (63) Chief Financial & Bus. Officer
- Mr. Robert Michael Savel II (57) Chief Technical Officer